A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

被引:0
|
作者
Véronique Diéras
Jean Paul Guastalla
Jean Marc Ferrero
Hervé Curé
Béatrice Weber
Philippe Winckel
Alain Lortholary
Françoise Mayer
Désiré Paraiso
Emmanuelle Magherini
Eric Pujade-Lauraine
机构
[1] Institut Curie,Department of Medical Oncology
[2] Centre Léon Bérard,undefined
[3] Centre Antoine Lacassagne,undefined
[4] Centre Jean Perrin,undefined
[5] Centre Alexis Vautrin,undefined
[6] Clinique du Mail,undefined
[7] Centre Paul Papin,undefined
[8] Centre Georges François Leclerc,undefined
[9] CHU Hôtel-Dieu,undefined
[10] Laboratoire Aventis,undefined
来源
关键词
Docetaxel; Cisplatin; Ovarian cancer; Taxanes; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:489 / 495
页数:6
相关论文
共 50 条
  • [1] A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer:: a GINECO study
    Diéras, V
    Guastalla, JP
    Ferrero, JM
    Curé, H
    Weber, B
    Winckel, P
    Lortholary, A
    Mayer, F
    Paraiso, D
    Magherini, E
    Pujade-Lauraine, E
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (06) : 489 - 495
  • [2] First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
    Georgoulias, V
    Androulakis, N
    Dimopoulos, AM
    Kourousis, C
    Kakolyris, S
    Papadakis, E
    Apostolopoulou, F
    Papadimitriou, C
    Vossos, A
    Agelidou, M
    Heras, P
    Tzannes, S
    Vlachonicolis, J
    Mavromanolakis, E
    Hatzidaki, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (03) : 331 - 334
  • [3] Cisplatin-docetaxel (Taxotere®) in first line treatment of advanced ovarian cancer (AOC)
    Dieras, V
    Ferrero, JM
    Kheder, R
    Weber, B
    Winckel, P
    Lortho-lary, A
    Mayer, F
    Paraiso, DJ
    Pujade-Lauraine, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S243 - S243
  • [4] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [6] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    G. Quintero-Aldana
    M. Jorge
    C. Grande
    M. Salgado
    E. Gallardo
    S. Varela
    C. López
    M. J. Villanueva
    A. Fernández
    E. Alvarez
    P. González
    J. Castellanos
    J. Casal
    R. López
    B. Campos Balea
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
  • [7] Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study
    Ardavanis, A
    Tryfonopoulos, D
    Alexopoulos, A
    Kandylis, C
    Lainakis, G
    Rigatos, G
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (04) : 645 - 650
  • [8] Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study
    Belpomme, D
    Krakowski, I
    Beauduin, M
    Petit, T
    Canon, JL
    Janssens, J
    Gauthier, S
    De Pauw, A
    Moreau, V
    Kayitalire, L
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 91 (01) : 32 - 38
  • [9] A Phase II Study of Weekly Docetaxel-Cisplatin As First-Line Treatment for Advanced Non-small Cell Lung Cancer
    Binder, Daniel
    Hackenthal, Matthias
    Graseck, Lutz
    Schweisfurth, Hans
    Schaeper, Christoph
    Kruell, Matthias
    Temmesfeld-Wollbrueck, Bettina
    Suttorp, Norbert
    Suttorp, Thomas
    Beinert, Thomas
    Hellriegel, Klaus-Peter
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : 1144 - 1147
  • [10] Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study
    A Ardavanis
    D Tryfonopoulos
    A Alexopoulos
    C Kandylis
    G Lainakis
    G Rigatos
    [J]. British Journal of Cancer, 2005, 92 : 645 - 650